Introduction
Topical photodynamic therapy (PDT) relies on the interaction between light, molecular oxygen and a photosensitive chemical to produce singlet oxygen and other reactive oxygen species (ROS), leading to tissue injury and death of targeted cells [1] . PDT is a well established method for treating superficial skin lesions such as basal cell carcinoma (BCC), Bowen's disease (BD) and actinic keratosis (AK) [2] . During topical photodynamic therapy (PDT), the prodrug aminolevulinic acid (ALA) or methyl aminolevulinate (MAL) is applied topically to the skin.
After the application of the prodrug the lesion is covered with an occlusive dressing which blocks out any ambient light. During this occlusive treatment (with a typical duration of three hours) the prodrug diffuses through the skin and is converted to the photosensitive molecule protoporphyrin IX (PpIX) in the tumour cells [3] . PpIX is a naturally occurring molecule which Even though PDT is a well established treatment method, there is still a desire to improve the response rate. One suggested reason for a reduced response rate is the insufficient accumulation of PpIX within the lesional tissue [4] . Typically the occlusive treatment phase (OTP) is three hours long, but improved results with a longer OTP have been reported [5] . The work presented here provides a study of the production of PpIX during the OTP to determine the rate at which PpIX builds up within the tumour tissue during the OTP where different lesion and patient characteristics are compared.
Many skin properties change when tissue is removed from the body. Thus it is important to consider in vivo data when investigating and representing skin dynamics during light based therapies such as PDT. Clinical studies are vital for development of the PDT treatment as well as determination of skin properties to allow accurate theoretical simulations. In PDT the in vivo data acquisition is mostly limited to surface measurements, due to the non-invasive nature of the treatment. One measurable quantity is the characteristic fluorescence signal associated with the PpIX molecule, where the level of measured fluorescence is used as an indicator of the amount of PpIX present within the skin tissue [6] . It is important to be aware of the limitations of the penetration of light through tissue which means that fluorescence from depth will be attenuated to some extent when measured at the skin surface. In this study fluorescence observations were used to measure the production of PpIX during the OCP.
M a n u s c r i p t 
Photosensitiser
The pro-drug that was used contained 20% MAL (PDTPharma LTDA., Cravinhos-SP, Brazil)
which was converted to ALA that subsequently induced the production of PpIX within the mitochondria. Both ALA and PpIX are naturally occurring in human cells and are main components in heme production. Exogenous addition of ALA leads to bypassing of rate limiting steps and accumulation of PpIX in tumour cells [3] .
Fluorescence device
The fluorescence measurements were recorded using an optical biopsy system (OBS) illustrated in figure 1 . The OBS houses a blue, 405 nm laser diode (approximately 1mW output), which is coupled to a fibre probe (diameter of 600 µm). The probe was used both for the excitation light as well as collecting the resulting fluorescence. A 455 nm long-pass filter and a fibre splitter are included in the OBS to allow the excitation light and collected signal to be separated and the M a n u s c r i p t backscattered light from the excitation to be eliminated from the recorded spectra. The collected light was recorded using a compact grating spectrometer (Ocean Optics, Inc.) interfaced with a PC.
Study design
Appropriate lesions were examined and selected for the study by a qualified dermatologist. All lesions were photographed, measured and biopsied to ensure correct identification. Before the prodrug was added to the lesion, a curettage was applied to remove the surface crust to improve penetration of the prodrug.The biopsy that was removed during the curettage was sent away for analysis. After the cream application (containing MAL), the lesion was covered with a PVC plastic film, aluminium foil and a compress, which was secured with surgical tape. The occlu- Following the occlusive treatment the lesion was treated using a therapeutic light source for 20 min [7] . The measurements were performed under such conditions that it was assumed to not affect the build up of PpIX within the tumour lesion.
Statistical analysis
Our aim was to generate a statistical model that accurately predicts the fluorescence signal as it changes with time for different patient characteristics such as skin type and lesion types. When measuring a longitudinal data set, correlation between the measured data points is present. For this reason the data points cannot be assumed to be independent and simple linear regression is not appropriate. In addition the spread of the data was proven to not be normal nor homogenous, which indicates that generalised statistical models are required.
A common and convenient way of modelling variation between individuals within a data set is by adopting random effects. The random effects represent the variation not explained by the covariates (fixed effects). The difference in, for example, genetic make up associated with different individuals results in different PpIX production rates. This effect is not considered within the fixed effects model and by including the random effects associated with the individual and explaining the associated noise, the information gained from the estimated model can be applied to the wider population and not only the small subset of patients included in the study. A c c e p t e d M a n u s c r i p t A mixed effects model considers the correlation between repeated measurements as well as the longitudinal correlations [8] . This makes generalised mixed effects models (GLMMs) the most appropriate framework to adopt in the presented study. All statistical analysis was carried out in R [9] .
3 Results An initial analysis showed that the data collected here gives the linear trend that has previously been suggested [10, 11] . For this reason the adopted model was assumed to follow a positive linear trend. Since all data points were background subtracted, the y-intercept was forced to the origin. The skewness of the residuals in combination with the requirement of a positive continuous model indicates a Gamma distribution of the observations, where the variance increases quadratically with expectations [8, 12] .
To consider the correlations as well as random effects, a GLMM was adopted using the 'glmmPQL' function in the 'MASS' package in R. The explanatory variables that were investigated were: gender, location of the lesion, skin type and type of lesion. During the first treatment session the results show that there was no significant difference associated with gender, skin type or lesion type. However, the GLMM showed that there was a signifiant difference PpIX production during the occlusive treatment face compared to other lesion locations. Figure   4 shows the linear trends associated with the lesion locations.
Discussion
Our results suggested that the strength of the fluorescence signal is affected by the location of the lesion supporting previous findings [13, 14] . Other characteristics such as lesion type, gender and skin type did not show any significant difference. The effect of gender and skin type could be explained by the fact that these should not have an effect on the lesion itself. A more significant difference between lesion type (when comparing AK and BCC) was expected both due to the potential anatomical and physiological variation between lesion types as well as previous published results [10] . In addition the difference in diffusion barrier between different individuals (affected by both lesion type and location of the lesion) will influence the penetration of the prodrug and thereby the distribution of the PpIX. However, no significant difference was found within the data obtained within this study.
Since the light source in the OBS is blue, the penetration of this light is as previously mentioned, limited. This means that the whole depth of the lesion might not be measured successfully. PpIX from depths beyond the measuring range will therefore not contribute to this study.
To remove this limitation further investigations are encouraged. This would include measurements of biopsied sample sections as well as using alternative deeper penetrating light sources to measure the fluorescence.
The linear trend was found to be an appropriate fit for our data and is, as previously mentioned, supported by previous studies [10, 11] . There is no way of determining the trend after the three hours of occlusive treatment. It could be argued that the linear trend would flatten out if the occlusive treatment was extended due to the saturation of the PpIX. To measure this, A c c e p t e d M a n u s c r i p t the subjects would have to stay in the clinic for a longer period of time and the PDT treatment would not be able to be performed according to the regulated protocol. In a previous study, where the fluorescence was studied in healthy human skin, no significance was observed when ALA was applied for 1 hours or 6 hours. This shows that the differences between NMSC and healthy skin modifies the PpIX production kinetics [15] .
The results show a large variation within patients as well as between patients. This could be explained by the non-uniform nature of tumour tissue. Even though the same area was targeted for the repeated measurements, non-uniformities on small size-scales can lead to large variations in the fluorescence signal [16] .
Due to the slight variation in surface preparation (degree of curettage) between institutes a study which considers this would be appropriate. Including several institutes would strengthen the results and increase the number of patients included in the study.
The statistical framework that was developed for this study should be considered for other clinical studies. By considering the correlation, more appropriate results and conclusions can be drawn from clinical data. The collected data extends the previous knowledge where the frequency of measurements was increased as well as the comparison between more explanatory variables, has to our knowledge, not previously been undertaken.
Conclusion
The PpIX fluorescence signal from patients presented with superficial skin lesions (BCC and AK) was measured at a regular time interval during a three hour long OTP. It was found that the PpIX increased linearly during the first three hours of the occlusive phase where results indicate a larger overall amount of PpIX produced in lesions located on the face compared to all other body location. Even though the results show a large variability both intra-and inter-subject, the linear trend supports previously published data. This study extends and supports previous 
